L9LS in Women of Childbearing Potential in Mali

NCT07060508 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

290

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: Single dose of 1800 mg L9LS SC
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]